95 related articles for article (PubMed ID: 9932837)
1. Unraveling obesity.
Hom X; Kleinman R
J Pediatr Gastroenterol Nutr; 1999 Feb; 28(2):121-2. PubMed ID: 9932837
[No Abstract] [Full Text] [Related]
2. New insights into obesity genes.
Guerre-Millo M; Staels B; Auwerx J
Diabetologia; 1996 Dec; 39(12):1528-31. PubMed ID: 8960837
[No Abstract] [Full Text] [Related]
3. A genetic mutation in PPAR gamma is associated with enhanced fat cell differentiation: implications for human obesity.
Freake HC
Nutr Rev; 1999 May; 57(5 Pt 1):154-6. PubMed ID: 10391018
[TBL] [Abstract][Full Text] [Related]
4. Becoming fat.
Lazar MA
Genes Dev; 2002 Jan; 16(1):1-5. PubMed ID: 11782439
[No Abstract] [Full Text] [Related]
5. Nutrient channelling-regulated peroxisome proliferator-activated receptor-gamma-2 (PPARgamma-2) and leptin gene expression in human subcutaneous fat.
Nisoli E; Vettor R; Tonello C; Macor C; Federspil G; Carruba MO
Diabetologia; 1999 Apr; 42(4):495-7. PubMed ID: 10230656
[No Abstract] [Full Text] [Related]
6. PPAR gamma and the molecular control of adipogenesis.
Brun RP; Spiegelman BM
J Endocrinol; 1997 Nov; 155(2):217-8. PubMed ID: 9415052
[No Abstract] [Full Text] [Related]
7. Obesity associated with a mutation in a genetic regulator of adipocyte differentiation.
Ristow M; Müller-Wieland D; Pfeiffer A; Krone W; Kahn CR
N Engl J Med; 1998 Oct; 339(14):953-9. PubMed ID: 9753710
[TBL] [Abstract][Full Text] [Related]
8. Adipocyte differentiation and leptin expression.
Hwang CS; Loftus TM; Mandrup S; Lane MD
Annu Rev Cell Dev Biol; 1997; 13():231-59. PubMed ID: 9442874
[TBL] [Abstract][Full Text] [Related]
9. Adipogenesis and obesity: rounding out the big picture.
Spiegelman BM; Flier JS
Cell; 1996 Nov; 87(3):377-89. PubMed ID: 8898192
[No Abstract] [Full Text] [Related]
10. Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
Kallen CB; Lazar MA
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):5793-6. PubMed ID: 8650171
[TBL] [Abstract][Full Text] [Related]
11. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans.
Meirhaeghe A; Fajas L; Helbecque N; Cottel D; Lebel P; Dallongeville J; Deeb S; Auwerx J; Amouyel P
Hum Mol Genet; 1998 Mar; 7(3):435-40. PubMed ID: 9467001
[TBL] [Abstract][Full Text] [Related]
12. Dehydroepiandrosterone down-regulates the expression of peroxisome proliferator-activated receptor gamma in adipocytes.
Kajita K; Ishizuka T; Mune T; Miura A; Ishizawa M; Kanoh Y; Kawai Y; Natsume Y; Yasuda K
Endocrinology; 2003 Jan; 144(1):253-9. PubMed ID: 12488352
[TBL] [Abstract][Full Text] [Related]
13. Adipose peroxisome proliferator-activated receptor gamma mRNA expression in insulin-resistant obese patients: relationship with adipocyte membrane phospholipids.
Zeghari N; Vidal H; Perche S; Meyer L; Ziegler O; Guerci B; Donner M; Drouin P
Lipids; 1999; 34 Suppl():S161. PubMed ID: 10419134
[No Abstract] [Full Text] [Related]
14. Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients.
Auboeuf D; Rieusset J; Fajas L; Vallier P; Frering V; Riou JP; Staels B; Auwerx J; Laville M; Vidal H
Diabetes; 1997 Aug; 46(8):1319-27. PubMed ID: 9231657
[TBL] [Abstract][Full Text] [Related]
15. Pluripotent PPARgamma polymorphisms.
Berg JP
Eur J Endocrinol; 1999 Apr; 140(4):293-5. PubMed ID: 10097247
[No Abstract] [Full Text] [Related]
16. Function of GATA transcription factors in preadipocyte-adipocyte transition.
Tong Q; Dalgin G; Xu H; Ting CN; Leiden JM; Hotamisligil GS
Science; 2000 Oct; 290(5489):134-8. PubMed ID: 11021798
[TBL] [Abstract][Full Text] [Related]
17. 15-Deoxy-delta(12,14) prostaglandin J2: a putative endogenous promoter of adipogenesis suppresses the ob gene.
Sinha D; Addya S; Murer E; Boden G
Metabolism; 1999 Jun; 48(6):786-91. PubMed ID: 10381155
[TBL] [Abstract][Full Text] [Related]
18. The Pro-115 --> Gln mutation in peroxisome-proliferator-activated receptor (PPAR) gamma2 is extremely rare in a large cohort of U.S. Caucasians.
Terrett J; Chamberlain J; Rastan S; Marshall R; McGinnis R; Spurr N; O'Brien E; Evans C; Rut A
Clin Sci (Lond); 2000 Jul; 99(1):89-90. PubMed ID: 10887062
[No Abstract] [Full Text] [Related]
19. Insulin resistance and obesity.
Schwartz MW; Kahn SE
Nature; 1999 Dec 23-30; 402(6764):860-1. PubMed ID: 10622250
[No Abstract] [Full Text] [Related]
20. The silent PPARgamma exon 6 CAC(His) --> CAT(His) polymorphism does not affect the plasma leptin levels in a collective of first degree relatives of type 2 diabetes patients from South West Germany.
Koch M; Rett K; Maerker E; Volk A; Haist K; Deninger M; Rettig A; Renn W; Häring HU
Exp Clin Endocrinol Diabetes; 2000; 108(5):341-6. PubMed ID: 10989952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
